BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 26111720)

  • 1. The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression.
    Kim YK; Na KS; Myint AM; Leonard BE
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():277-84. PubMed ID: 26111720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia.
    Na KS; Jung HY; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():277-86. PubMed ID: 23123365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroimmune and neuroendocrine abnormalities in depression: two sides of the same coin.
    Horowitz MA; Zunszain PA
    Ann N Y Acad Sci; 2015 Sep; 1351():68-79. PubMed ID: 25943397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines mediated inflammation and decreased neurogenesis in animal models of depression.
    Song C; Wang H
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):760-8. PubMed ID: 20600462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines and glucocorticoid receptors are associated with the antidepressant-like effect of alarin.
    Zhuang F; Zhou X; Gao X; Lou D; Bi X; Qin S; Sun C; Ye P; Wang Y; Ma T; Li M; Gu S
    Peptides; 2016 Feb; 76():115-29. PubMed ID: 26779986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression.
    Pace TW; Hu F; Miller AH
    Brain Behav Immun; 2007 Jan; 21(1):9-19. PubMed ID: 17070667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal neurogenesis dysfunction linked to depressive-like behaviors in a neuroinflammation induced model of depression.
    Tang MM; Lin WJ; Pan YQ; Guan XT; Li YC
    Physiol Behav; 2016 Jul; 161():166-173. PubMed ID: 27106565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines: abnormalities in major depression and implications for pharmacological treatment.
    O'Brien SM; Scott LV; Dinan TG
    Hum Psychopharmacol; 2004 Aug; 19(6):397-403. PubMed ID: 15303243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation?
    Farooq RK; Isingrini E; Tanti A; Le Guisquet AM; Arlicot N; Minier F; Leman S; Chalon S; Belzung C; Camus V
    Behav Brain Res; 2012 May; 231(1):130-7. PubMed ID: 22465167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain-immune interactions and implications in psychiatric disorders].
    Marques AH; Cizza G; Sternberg E
    Braz J Psychiatry; 2007 May; 29 Suppl 1():S27-32. PubMed ID: 17546344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation and cytokine abnormality in major depression: Cause or consequence in that illness?
    Jeon SW; Kim YK
    World J Psychiatry; 2016 Sep; 6(3):283-93. PubMed ID: 27679767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroinflammation and depression: A review.
    Troubat R; Barone P; Leman S; Desmidt T; Cressant A; Atanasova B; Brizard B; El Hage W; Surget A; Belzung C; Camus V
    Eur J Neurosci; 2021 Jan; 53(1):151-171. PubMed ID: 32150310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimmune Advance in Depressive Disorder.
    Zhao G; Liu X
    Adv Exp Med Biol; 2019; 1180():85-98. PubMed ID: 31784958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Chemokines in the Pathophysiology of Major Depressive Disorder.
    Milenkovic VM; Stanton EH; Nothdurfter C; Rupprecht R; Wetzel CH
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31075818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
    Gaab J; Rohleder N; Heitz V; Engert V; Schad T; Schürmeyer TH; Ehlert U
    Psychoneuroendocrinology; 2005 Feb; 30(2):188-98. PubMed ID: 15471616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids, cytokines and brain abnormalities in depression.
    Zunszain PA; Anacker C; Cattaneo A; Carvalho LA; Pariante CM
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Apr; 35(3):722-9. PubMed ID: 20406665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules.
    Chesnokova V; Melmed S
    Endocrinology; 2002 May; 143(5):1571-4. PubMed ID: 11956136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence.
    Nunes SO; Vargas HO; Prado E; Barbosa DS; de Melo LP; Moylan S; Dodd S; Berk M
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1336-45. PubMed ID: 23660457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection in Schizophrenia and Its Therapeutic Implications.
    Kim YK; Na KS
    Psychiatry Investig; 2017 Jul; 14(4):383-391. PubMed ID: 28845163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.